Who makes Chowiseungcheng-tang?

Chowiseungcheng-tang is developed by Gachon University Gil Oriental Medical Hospital.

What development phase is Chowiseungcheng-tang in?

Chowiseungcheng-tang is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Chowiseungcheng-tang

Gachon University Gil Oriental Medical Hospital · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Chowiseungcheng-tang
Also known as	CST
Sponsor	Gachon University Gil Oriental Medical Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial - (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Chowiseungcheng-tang CI brief — competitive landscape report
Chowiseungcheng-tang updates RSS · CI watch RSS
Gachon University Gil Oriental Medical Hospital portfolio CI